Nycomed International Management GmbH · Zurich Switzerland
| Thurgauerstrasse 130, 8152 Glattpark-Opfikon | Phone: +41-44-555-10-00 |
| Zurich | Fax: +41-44-555-10-01 |
| CH-8050 | |
| Switzerland | 
Map This Company |
Nycomed International Management GmbH Rankings
Company Description
From aching hearts to brittle bones, if you suffer from it, Nycomed probably has a drug to help. The Swiss pharmaceutical company develops prescription and OTC medicines mainly focusing on cardiology, gastroenterology, osteoporosis, respiratory, and pain management therapies. It operates nearly 20 facilities in a dozen European countries, where it conducts its own research and drug testing. It also develops products in conjunction with partner pharmaceutical companies. The majority of Nycomed's revenues come from direct drug sales to doctors, hospitals, and pharmacies, as well as from licensing product rights to and from other companies. Nycomed was acquired by Japan's
Nycomed International Management GmbH Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | SubsidiaryHeadquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 3 |
Executives
18 executives listed for Nycomed International Management GmbH's Zurich, Switzerland location.
| Chairman | Toni Weitzberg | |
|---|---|---|
| CEO and Director | Håkan Björklund | |
| EVP Operations | Barthold Piening |